Beta Bionics, Inc. (BBNX) Free Cash Flow (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Free Cash Flow data on file, last reported at -$25.2 million in Q1 2026.

• Quarterly Free Cash Flow fell 24.13% year-over-year to -$25.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$61.1 million (down 2.86% YoY) and the FY2025 annual result came in at -$56.2 million, down 8.81% from the prior year.
• Free Cash Flow declined to -$25.2 million in Q1 2026 per BBNX's latest filing, from -$13.9 million in the prior quarter.
• The five-year high for Free Cash Flow was -$8.7 million in Q3 2025, with the low at -$25.2 million in Q1 2026.
• Average Free Cash Flow over 3 years is -$14.8 million, with a median of -$13.4 million recorded in 2025.
• The widest YoY moves for Free Cash Flow: up 24.58% in 2025, down 61.82% in 2025.
• Beta Bionics' Free Cash Flow stood at -$14.8 million in 2024, then rose by 6.43% to -$13.9 million in 2025, then tumbled by 81.54% to -$25.2 million in 2026.
• Business Quant data shows BBNX's Free Cash Flow at -$25.2 million in Q1 2026, -$13.9 million in Q4 2025, and -$8.7 million in Q3 2025.